SCHEMBL9107973

SCHEMBL9107973

CC(C)CC(C(=O)Nc1nccs1)N1C(=O)C(=O)c2ccccc21

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCK P35557 4/20 0.79
HSPA5 P11021 1/20 0.48
HSPA2 P54652 1/20 0.48
FFAR2 O15552 1/20 0.47
LMNA P02545 3/20 0.47
TSHR P16473 1/20 0.47
ALDH1A1 P00352 3/20 0.46
MEN1 O00255 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
EGFR P00533 1/20 0.46
HSD17B10 Q99714 2/20 0.46
ACP1 P24666 1/20 0.46
GAA P10253 1/20 0.45
XBP1 P17861 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1317245 0.88 GCK (1.00) GCKHSPA5HSPA2FFAR2LMNA
SCHEMBL9103861 0.87 GCK (0.66) GCKHSPA5HSPA2FFAR2LMNA
SCHEMBL9106076 0.87 GCK (0.66) GCKHSPA5HSPA2FFAR2LMNA
SCHEMBL9106679 0.86 GCK (0.64) GCKHSPA5HSPA2FFAR2LMNA
SCHEMBL9103438 0.86 GCK (0.64) GCKHSPA5HSPA2FFAR2LMNA
SCHEMBL9101953 0.85 GCK (0.66) GCKHSPA5HSPA2FFAR2LMNA
SCHEMBL9103462 0.85 GCK (0.62) GCKHSPA5HSPA2FFAR2LMNA
SCHEMBL9109015 0.82 GCK (0.59) GCK
SCHEMBL9108958 0.82 GCK (0.53) GCKLMNATSHRALDH1A1MEN1
SCHEMBL9105720 0.82 GCK (0.58) GCKHSPA5HSPA2FFAR2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US claimed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS GPR119, INSR, OAT GCK 488/4885HSPA5 1634/4885HSPA2 2274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.